Donald Huffman

Donald Huffman

No open positions remaining
79 year
Health Technology
Consumer Services
Finance

Profile

Donald D.
Huffman
served as Chief Financial Officer at Celtrix Pharmaceuticals, Inc. from 1981 to 2000.
Held Chief Financial Officer roles at Sanderling Management CO LLC (2004-2006), Guava Technologies, Inc. (2006-2008), Asante Solutions, Inc. (2008-2010), and WaferGen Bio-systems, Inc. (2010-2012).
Occupied Chief Executive Officer & Chief Financial Officer positions at WaferGen Bio-systems, Inc. from 2010 to 2012.
Served as Director at Aerami Therapeutics, Inc. (2013-2014), SteadyMed Therapeutics, Inc. (2015-2018), and Aerami Therapeutics Holdings, Inc. Also held External Director role at SteadyMed Ltd. (2015-2018).
Chief Executive Officer & Director at Amarantus Bioscience Holdings, Inc. from 2021 to 2025.
Held Chief Financial Officer roles at Merck & Co., Inc., Essential Therapeutics, Inc., Philips Image Guided Therapy Corp., and Genteric, Inc. Education includes undergraduate degree from The Pennsylvania State University and MBA from State University of New York at Buffalo.

Former positions of Donald Huffman

CompaniesPositionEnd
AMARANTUS BIOSCIENCE HOLDINGS, INC. Chief Executive Officer 01/10/2025
STEADYMED LTD Director/Board Member 30/08/2018
Director/Board Member 01/01/2018
WAFERGEN BIO-SYSTEMS, INC. Director of Finance/CFO 26/03/2012
ASANTE SOLUTIONS INC Director of Finance/CFO 01/09/2010
See the detail of Donald Huffman's experience

Training of Donald Huffman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

32

1st degree connections

16

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies16

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Donald Huffman